Antimicrobial Resistance Surveillance Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Antimicrobial Resistance Surveillance Market Report is Segmented by Solution (kits, Systems, Surveillance Software, Surveillance Services), Application (clinical Diagnostics, Public Health Surveillance, Other Applications), End User (hospitals and Clinics, Diagnostic Centers, Other End-Users), and Geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

Antimicrobial Resistance Surveillance Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Antimicrobial Resistance Surveillance Industry Overview

The antimicrobial resistance surveillance market is moderately consolidated and competitive due to the presence of many players. The market's major players are concentrating on joint ventures, strategic alliances, introducing new products, and geographic growth into developing and economically advantageous areas. Some of the major players include Thermo Fisher Scientific, Pfizer Inc., Cepheid, Accelerate Diagnostics, In, Liofilchem S.r.l., Becton Dickinson and Company, Biomerieux, Bruker, Merck KgaA, Bio-Rad Laboratories, Inc., Qiagen, SyntBioLab INC, Sysmex Inostics, Guardant Health, Inc, Exact Sciences Corporation.

Antimicrobial Resistance Surveillance Market Leaders

  1. Pfizer Inc.

  2. Merck KgaA

  3. Thermo Fisher Scientific

  4. Cepheid

  5. Liofilchem S.r.l.

  6. *Disclaimer: Major Players sorted in no particular order
Antimicrobial Resistance Surveillance Market Concentration